These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

274 related items for PubMed ID: 31123815

  • 1. Patient characteristics of untreated chronic central serous chorioretinopathy patients with focal versus diffuse leakage.
    van Rijssen TJ, van Dijk EHC, Scholz P, Breukink MB, Blanco-Garavito R, Souied EH, MacLaren RE, Querques G, Fauser S, Hoyng CB, Downes SM, Boon CJF.
    Graefes Arch Clin Exp Ophthalmol; 2019 Jul; 257(7):1419-1425. PubMed ID: 31123815
    [Abstract] [Full Text] [Related]

  • 2. Clinical characteristics of chronic central serous chorioretinopathy patients with insufficient response to reduced-settings photodynamic therapy.
    van Rijssen TJ, van Dijk EHC, Dijkman G, Boon CJF.
    Graefes Arch Clin Exp Ophthalmol; 2018 Aug; 256(8):1395-1402. PubMed ID: 29732468
    [Abstract] [Full Text] [Related]

  • 3. Focal and Diffuse Chronic Central Serous Chorioretinopathy Treated With Half-Dose Photodynamic Therapy or Subthreshold Micropulse Laser: PLACE Trial Report No. 3.
    van Rijssen TJ, van Dijk EHC, Scholz P, Breukink MB, Blanco-Garavito R, Souied EH, Keunen JEE, MacLaren RE, Querques G, Fauser S, Downes SM, Hoyng CB, Boon CJF.
    Am J Ophthalmol; 2019 Sep; 205():1-10. PubMed ID: 30951686
    [Abstract] [Full Text] [Related]

  • 4. Photodynamic therapy in chronic central serous chorioretinopathy with subretinal fluid outside the fovea.
    van Dijk EHC, Dijkman G, Boon CJF.
    Graefes Arch Clin Exp Ophthalmol; 2017 Oct; 255(10):2029-2035. PubMed ID: 28674835
    [Abstract] [Full Text] [Related]

  • 5. Impairment of visual acuity and retinal morphology following resolved chronic central serous chorioretinopathy.
    Gawęcki M, Jaszczuk-Maciejewska A, Jurska-Jaśko A, Kneba M, Grzybowski A.
    BMC Ophthalmol; 2019 Jul 25; 19(1):160. PubMed ID: 31345183
    [Abstract] [Full Text] [Related]

  • 6. Optical coherence tomography angiography versus fluorescein angiography in diagnosing choroidal neovascularization in chronic central serous chorioretinopathy.
    Bansal R, Dogra M, Mulkutkar S, Katoch D, Singh R, Gupta V, Dogra MR, Gupta A.
    Indian J Ophthalmol; 2019 Jul 25; 67(7):1095-1100. PubMed ID: 31238419
    [Abstract] [Full Text] [Related]

  • 7. OCT Angiography Compared to Fluorescein and Indocyanine Green Angiography in Chronic Central Serous Chorioretinopathy.
    Teussink MM, Breukink MB, van Grinsven MJ, Hoyng CB, Klevering BJ, Boon CJ, de Jong EK, Theelen T.
    Invest Ophthalmol Vis Sci; 2015 Aug 25; 56(9):5229-37. PubMed ID: 26244299
    [Abstract] [Full Text] [Related]

  • 8. Effect of Photodynamic Therapy on Optical Coherence Tomography Angiography in Eyes with Chronic Central Serous Chorioretinopathy.
    Xu Y, Su Y, Li L, Qi H, Zheng H, Chen C.
    Ophthalmologica; 2017 Aug 25; 237(3):167-172. PubMed ID: 28171871
    [Abstract] [Full Text] [Related]

  • 9. Selective retina therapy with automatic real-time feedback-controlled dosimetry for chronic central serous chorioretinopathy in Korean patients.
    Park YG, Kang S, Kim M, Yoo N, Roh YJ.
    Graefes Arch Clin Exp Ophthalmol; 2017 Jul 25; 255(7):1375-1383. PubMed ID: 28421342
    [Abstract] [Full Text] [Related]

  • 10. Assessment of macular choroidal thickness by optical coherence tomography and angiographic changes in central serous chorioretinopathy.
    Jirarattanasopa P, Ooto S, Tsujikawa A, Yamashiro K, Hangai M, Hirata M, Matsumoto A, Yoshimura N.
    Ophthalmology; 2012 Aug 25; 119(8):1666-78. PubMed ID: 22521082
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. RISK FACTORS FOR RECURRENCES OF CENTRAL SEROUS CHORIORETINOPATHY.
    Matet A, Daruich A, Zola M, Behar-Cohen F.
    Retina; 2018 Jul 25; 38(7):1403-1414. PubMed ID: 28570485
    [Abstract] [Full Text] [Related]

  • 13. Multimodal Imaging in Fibrinous Central Serous Chorioretinopathy Compared with Exudative Maculopathy.
    Lyu Y, Li X, Gong Y.
    Ophthalmologica; 2020 Jul 25; 243(5):360-369. PubMed ID: 32008002
    [Abstract] [Full Text] [Related]

  • 14. CONCURRENT IDIOPATHIC MACULAR TELANGIECTASIA TYPE 2 AND CENTRAL SEROUS CHORIORETINOPATHY.
    Matet A, Yzer S, Chew EY, Daruich A, Behar-Cohen F, Spaide RF.
    Retina; 2018 Jan 25; 38 Suppl 1(Suppl 1):S67-S78. PubMed ID: 29016451
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. TWELVE-MONTH EFFICACY OF INTRAVITREAL BEVACIZUMAB INJECTION FOR CHRONIC, ATYPICAL, OR RECURRENT CENTRAL SEROUS CHORIORETINOPATHY.
    Chung YR, Kim JW, Song JH, Park A, Kim MH.
    Retina; 2019 Jan 25; 39(1):134-142. PubMed ID: 29077604
    [Abstract] [Full Text] [Related]

  • 17. Retinoschisis in eyes with pachychoroid and retinal pigment epithelial atrophy.
    Baek J, Lee JH, Lee WK.
    Graefes Arch Clin Exp Ophthalmol; 2019 Sep 25; 257(9):1863-1871. PubMed ID: 31222406
    [Abstract] [Full Text] [Related]

  • 18. Pachychoroid neovasculopathy: aspect on optical coherence tomography angiography.
    Azar G, Wolff B, Mauget-Faÿsse M, Rispoli M, Savastano MC, Lumbroso B.
    Acta Ophthalmol; 2017 Jun 25; 95(4):421-427. PubMed ID: 27597633
    [Abstract] [Full Text] [Related]

  • 19. CLINICAL CHARACTERISTICS AND OUTCOME OF POSTERIOR CYSTOID MACULAR DEGENERATION IN CHRONIC CENTRAL SEROUS CHORIORETINOPATHY.
    Mohabati D, Hoyng CB, Yzer S, Boon CJF.
    Retina; 2020 Sep 25; 40(9):1742-1750. PubMed ID: 31815880
    [Abstract] [Full Text] [Related]

  • 20. Central serous chorioretinopathy in elderly subjects: angiographic and tomographic characteristics.
    Bae K, Nam SW, Kang SW, Kim ES, Yu SY, Kim KT, Kim SJ.
    Graefes Arch Clin Exp Ophthalmol; 2019 Feb 25; 257(2):279-288. PubMed ID: 30564905
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.